Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000156850 | SCV000206571 | uncertain significance | not specified | 2014-10-08 | criteria provided, single submitter | clinical testing | The p.Thr30124Arg variant in TTN has not been previously reported in individuals with cardiomyopathy or in large population studies. Computational prediction to ols and conservation analysis do not provide strong support for or against an im pact to the protein. In summary, the clinical significance of the p.Thr30124Arg variant is uncertain. |
Labcorp Genetics |
RCV000642991 | SCV000764678 | uncertain significance | Dilated cardiomyopathy 1G; Autosomal recessive limb-girdle muscular dystrophy type 2J | 2017-10-30 | criteria provided, single submitter | clinical testing | |
Revvity Omics, |
RCV003137687 | SCV003822835 | uncertain significance | not provided | 2019-06-27 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV004734745 | SCV005357298 | uncertain significance | TTN-related disorder | 2024-07-11 | no assertion criteria provided | clinical testing | The TTN c.98075C>G variant is predicted to result in the amino acid substitution p.Thr32692Arg. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.053% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. Although we suspect that this variant may be benign, at this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |